Emcure Pharmaceuticals Ltd. is proposing an Initial Public Offering (IPO) on the NSE & BSE platform under the Mainboard category.
Subscription opens 03 Jul 2024, closes 05 Jul 2024. Listing expected 13 Jul 2024. Apply via ASBA or UPI.
Emcure Pharmaceuticals Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 14 | ₹14,112 |
| Retail (Max) | 13 | 182 | ₹183,456 |
| sNII (Min) | 15 | 210 | ₹211,680 |
| bNII (Min) | 71 | 994 | ₹1,001,952 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |